UN Fee removes hashish from the record of harmful medicine

VIENNA – The United Nations Commission on Narcotic Drugswill be removed according to the recommendations of the World Health Organization for 2019 Cannabis from its strictest classification of dangerous drugs. The international peacekeeping body announced the decision on December 2nd.

“In January 2019 the World health organization (WHO) made a number of recommendations to change the scope of control of cannabis and cannabis-related substances, ”said an official statement from the commission. “After much deliberation, the Commission took action today on these recommendations.”

The WHO had classified cannabis, its psychoactive compound tetrahydrocannabinol (THC), and cannabis extracts as “dangerous drugs” since the drug was introduced Uniform Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol (Appendices I and IV: Cannabis and Cannabis Resin; Appendix I: Extracts and Tinctures of Cannabis). The action by the UN Commission on Narcotic Drugs removes cannabis from the stricter Appendix IV classification, but the plant and its compounds remain listed in Appendix I.

The move could ease international restrictions on cannabis and open the door to increased cannabis research worldwide.

The 53-member commission approved the action with 27 to 25 votes with one abstention. According to media reports, member nation Russia was against the change in planning and described cannabis as “the most abused substance in the world”.

Ethan Glick, the US representative too U.N. The affairs of the US Mission to International Organizations in Vienna approved the reclassification, with the US citing scientific evidence of the medicinal use of cannabis, but also recognizing potential “public health risks”.

Glick also cited U.S. Food and Drug Administration approval for the prescription seizure drug Epidiolex, a formulation developed by CBD GW Pharmaceuticals. Glick said further research into the medical benefits should continue.

The WHO’s 2019 recommendations, which also included cannabis formulations, may be effective in treating various conditions such as pain, nausea, anorexia, epilepsy and multiple sclerosis.

A statement on the US yes vote of the US mission to international organizations in Vienna Read: “The United States’ vote to remove cannabis and cannabis resin from Appendix IV of the Single Convention while maintaining them in Appendix I is consistent with science showing that cannabis was self-developed, although safe and An effective therapeutic agent developed from cannabis continues to pose a significant public health risk and should continue to be controlled under international drug control conventions. “

An international coalition of Cannabis advocacy groups Commenting on the decision in a public statement, he said: “Today the international community is taking a step forward with this small victory in medical cannabis, but the decolonization and modernization of the UN drug treaty regime is only just beginning. The outcome of this review process has again shown that the 1961 Single Convention is out of date and too blunt an instrument to fulfill its mandate to protect the health and well-being of humanity.

“It also demonstrated the profound division and paralysis within the international drug control system. With few signs of reconciliation between the reform-oriented countries and the defenders of the status quo of the drug war, the reformers will continue to tread a path forward that does not depend on a consensus in Vienna, as the national reforms currently in circulation show, “Director of the World Drugs and Democracy Program at the Transnational Institute Martin Jelsma said in a statement.

The vote on the planning status was the main topic on the agenda for the day, but the UN commission also touched on several other policy changes related to cannabis and cannabis products, and opposed other recommendations by the WHO.

In particular, a recommendation was rejected to reclassify cannabidiol, also known as the popular CBD supplement, and to remove it from “international control”. CBD, which is typically extracted from hemp, contains only trace amounts of the psychoactive compound THC.

Glick voted against the resolution, saying that CBD is not classified as a controlled substance in the US and therefore does not require reclassification. The connection should not be subject to international control, he added.

The European Association for Medical Cannabis protested the decision with a position paper entitled “CBD is not a narcotic drug.”

The cannabis vote took place after much deliberation. WHO’s recommendations were published in January 2019, but the UN commission postponed its vote to give member states more time to review and meet with hundreds of experts.

Comments are closed.